Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
BT-588 by Biotest for Community Acquired Pneumonia: Likelihood of Approval
BT-588 is under clinical development by Biotest and currently in Phase III for Community Acquired Pneumonia. According to GlobalData, Phase...
Data Insights
BT-588 by Biotest for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
BT-588 is under clinical development by Biotest and currently in Phase III for Coronavirus Disease 2019 (COVID-19). According to GlobalData,...